Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Xofigo (radium-223 dichloride) - Important Safety Information from Bayer Ltd. as approved by the HPRA
Notice type:
3rd Party Publications
Date:
01/04/2015
Problem Or Issue:
Important Safety Information communication from Bayer Ltd. on change in NIST Standard Reference Material for Xofigo (radium-223 dichloride).
Important Safety Information - Xofigo (radium-223 dichloride)
« Back
Date Printed: 19/04/2024